Navigation Links
Cookie Johnson and Abbott Bring 'I Stand With Magic: Campaign to End Black AIDS' to Los Angeles to Educate African-American Women on HIV/AIDS
Date:12/1/2007

including strengthening health care systems, supporting children affected by HIV/AIDS, and advancing HIV testing and treatment. For more information on Abbott's HIV/AIDS programs, please visit http://www.abbott.com/HIVAIDS and http://www.abbottglobalcare.org.

Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs 65,000 people and markets its products in more than 130 countries.

Abbott's news releases and other information are available on the company's Web site at http://www.abbott.com.


'/>"/>
SOURCE Abbott
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. A chocolate cookie a day puts 20 pounds on an energetically-balanced kid in 4 years
2. Johnson & Johnson to Participate in Bear Stearns 20th Annual Healthcare Conference
3. Draxis Health selected by Johnson and Johnson Consumer Companies, Inc. for major contract manufacturing relationship
4. Johnson & Johnson Campaign for Nursings Future Joins With AACN to Offer New Minority Nurse Faculty Scholars Program
5. Trust for Americas Health Receives $7.6 Million Grant from the Robert Wood Johnson Foundation to Advance the Quality and Impact of the Public Health System
6. Deane F. Johnson Center for Neurotherapeutics to Launch First Mobile Medical Unit on October 4th
7. Johnson & Johnson Tops Annual Pharmaceutical Company Rankings in a New Report From Industry-Leading Publication Scrip
8. Independence Technology, A Johnson & Johnson Company, Renews Its Contract With Creative Technology Services
9. Johnson & Johnson Launches Global Diabetes Institute to Provide State-of-The- Art Education, Training to Health Professionals
10. Robert Wood Johnson Foundation Announces $15.6 Million Grant to Apply Power of the Archimedes Model to Critical Health Care Decisions
11. UAN Mourns Passing of President Cheryl L. Johnson, RN
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... June 03, 2015 Hexagon Geospatial is ... winner of its 2015 U.S. Education Challenge, which showcases ... a college or university in the U.S. , ... focused on Remote Sensing and Civil Engineering at the ... “Pavement Surface Cracks Detection and Assessment Based on Hyper-spatial ...
(Date:6/3/2015)... June 03, 2015 Johnson & Johnson ... $7.8 million to resolve a Risperdal lawsuit ( http://www.risperdallawsuit2014.com/ ... the company allegedly used to market the antipsychotic drug. ... indicate that the Arkansas Attorney General moved to dismiss ... accord. The Risperdal settlement amounts to just a fraction ...
(Date:6/3/2015)... On June 22, 2015, Medicare will begin denying ... testing that it has reimbursed since 2009. , Payment ... of the 49 million Medicare beneficiaries in the U.S. who ... events.(1) Sadly, if it became a standard of care, this ... of an individual’s genetic information to tailor treatment, is by ...
(Date:6/3/2015)... Array Health , a leading ... that CEO Jonathan Rickert will present at America’s ... 4, 2015. The session will address the how the ... business models in health care, and why they are ... Digital Transformation and the Health Care Enterprise: Driving Business ...
(Date:6/3/2015)... Peter Piot, MD, PhD, will be honored with ... DIA’s Global Inspire Award program recognizes the organization’s outstanding ... to service on a global scale. , ... to Global Health that recognizes those who have made ... , “DIA is proud to honor Dr. Piot ...
Breaking Medicine News(10 mins):Health News:Hexagon Geospatial Announces U.S. Education Challenge Winner at HxGN Live 2015 2Health News:Risperdal Lawsuit News: Johnson & Johnson, Janssen Settle Arkansas Marketing Case for $7.8 Million 2Health News:Risperdal Lawsuit News: Johnson & Johnson, Janssen Settle Arkansas Marketing Case for $7.8 Million 3Health News:Risperdal Lawsuit News: Johnson & Johnson, Janssen Settle Arkansas Marketing Case for $7.8 Million 4Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 2Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 3Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 4Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 5Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 6Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 7Health News:Array Health’s CEO to Present at America’s Health Insurance Plans Institute 2015 2Health News:Co-discoverer of Ebola Virus and AIDS Pioneer to be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting 2Health News:Co-discoverer of Ebola Virus and AIDS Pioneer to be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting 3
... researchers at Rhode Island Hospital have found a substantial link ... with increased deaths from diseases, including Alzheimer,s, diabetes mellitus and ... Alzheimer,s Disease (Volume 17:3 July 2009). Led ... Hospital, researchers studied the trends in mortality rates due to ...
... ... following the Fourth of July break. To keep citizens aware of the dilemmas and decisions ... information. , ... July 5, 2009 -- After the Independence Day break, members of Congress will resume talks ...
... and fitness need not suffer, , SATURDAY, July 4 (HealthDay News) ... trying to save more and make do with less. But can ... it turns out, experts say you can -- if you,re smart ... still eating healthily, staying physically fit and receiving needed medical care. ...
... Darwish knows what it,s like being addicted to prescription pain ... Drug Problem Prescription Medication Abuse with CNN,s Rick ... how he got help, finally ending up at the ... program. , , *(Photo 72dpi: Send2Press.com/mediaboom/09-0703-NarcononMI_72dpi.jpg ...
... treatments, , FRIDAY, July 3 (HealthDay News) -- U.S. ... drive the rapid spread of relapsed lung cancer. , When ... cases are not detected until the disease is well advanced. ... disease often springs back more virulent than ever, frequently spreading ...
... ... Anti-Poverty Charity, Seeks Buyers for 35mm Michael Jackson Film Print of "Thriller" Music Video. ... Paterson, NJ ... anti-poverty charity, seeks serious inquiries only for historic 35mm film print of Michael Jackson,s ...
Cached Medicine News:Health News:Researchers find possible environmental causes for Alzheimer's, diabetes 2Health News:Researchers find possible environmental causes for Alzheimer's, diabetes 3Health News:Researchers find possible environmental causes for Alzheimer's, diabetes 4Health News:Congress Resumes Health Care Talks After Independence Day Break 2Health News:Living Healthily on Less 2Health News:Living Healthily on Less 3Health News:Living Healthily on Less 4Health News:Narconon Graduate Successfully Recovers From Prescription Drug Abuse 2Health News:Cell Pathway May Be Key to Lung Cancer's Spread 2Health News:Cell Pathway May Be Key to Lung Cancer's Spread 3Health News:A New Jersey Charity Seeks Serious Inquiries for Historic 35mm Film Print of Michael Jackson's "Thriller" Music Video 2Health News:A New Jersey Charity Seeks Serious Inquiries for Historic 35mm Film Print of Michael Jackson's "Thriller" Music Video 3Health News:A New Jersey Charity Seeks Serious Inquiries for Historic 35mm Film Print of Michael Jackson's "Thriller" Music Video 4Health News:A New Jersey Charity Seeks Serious Inquiries for Historic 35mm Film Print of Michael Jackson's "Thriller" Music Video 5
(Date:6/3/2015)... -- Ovarian Cancer Therapeutics in Asia-Pacific Markets to 2020 - ... GBI Research, a leading business intelligence provider, has released ... to 2020 - Off-patent Chemo-regimens to Retain Dominance Despite New ... 2013, along with forecasts until 2020 for the ... China , Australia ...
(Date:6/3/2015)... Fla. , June 3, 2015   ... adolescents and teens nationwide has prompted The Addiction ... detects drug usage in just 5 minutes. The ... with the tools to drug test for thirteen ... teens. Delivered in confidential packaging with instructions and ...
(Date:6/3/2015)... Research and Markets ( http://www.researchandmarkets.com/research/t3kkhg/the_future_of ) ... Future of Pharmaceutical Outsourcing" report to their ... desperate need to develop better drugs with high ... been increasingly utilizing external resources to increase their ... their internal operation. Their outsourcing demands and proportions ...
Breaking Medicine Technology:Ovarian Cancer Therapeutics in Asia-Pacific Markets to 2020 - Off-patent Chemo-regimens to Retain Dominance Despite New Launches 2Ovarian Cancer Therapeutics in Asia-Pacific Markets to 2020 - Off-patent Chemo-regimens to Retain Dominance Despite New Launches 3Ovarian Cancer Therapeutics in Asia-Pacific Markets to 2020 - Off-patent Chemo-regimens to Retain Dominance Despite New Launches 4The Drug Detective Is A Simple Test That Could Save Your Child's Life 2The Future of Pharmaceutical Outsourcing: 2015 Report 2
... , MORRISTOWN, N.J. , March 11 ... today announced the U.S. Food and Drug Administration (FDA) ... suspension), a new twice-yearly formulation of TRELSTAR®, a proven, ... With an anticipated May launch, TRELSTAR® 22.5 mg is ...
... , THOUSAND OAKS, Calif. , March 11 ... has received a US Patent Office Notice of Allowance ... expressing, secreting, and purifying the NELL-1 sequence of the ... a Chinese hamster ovary (CHO) cell. This patent continues ...
Cached Medicine Technology:FDA Approves Watson's TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer 2FDA Approves Watson's TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer 3FDA Approves Watson's TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer 4FDA Approves Watson's TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer 5FDA Approves Watson's TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer 6FDA Approves Watson's TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer 7FDA Approves Watson's TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer 8Bone Biologics Announces Another Major US Patent Issuance for Recombinant Protein Process 2Bone Biologics Announces Another Major US Patent Issuance for Recombinant Protein Process 3
The Accucount 2000 is designed to automatically count microscopic objects in a field displaying totals on a highly visible digital readout....
... Accelerated Bacterial Enumeration System. Bacterial concentration is ... found by the volume dispensed in the ... decreasing volume of sample is dispensed on ... in an Archimedes spiral. The volume is ...
... analyses the Petri dishes and counts the ... reproducible results. A CCD camera positioned above ... a dedicated computer. The counting alogrithms enable ... compensate for spreading and confluent colonies. The ...
... Gas Monitoring System provides a ... measurements of pH, pCO2, pO2 ... artery (e.g. radial, femoral or ... of O2 saturation; base-excess and ...
Medicine Products: